Edoardo Savarino

Associate Professor

University of Padua

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Edoardo Savarino is an Associate Professor at the University of Padua in Italy. His research areas include inflammatory bowel disease, precision oncology, and gastroenterology, as highlighted in his recent articles on the microbiota composition in ulcerative colitis, the effectiveness of tofacitinib and vedolizumab therapies, and the pathophysiology of gastroesophageal reflux disease. He is actively involved in studies addressing the impact of gastrointestinal conditions on patients' quality of life and the role of endoscopic biopsies in cancer outcomes.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (26)

Henit Yanai

ISRAEL

Edoardo Savarino

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Distinct microbiota composition and dendritic cell activation in the appendix microenvironment of ulcerative colitis patients

Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)

The current success of precision oncology relies on precision diagnostics: how quality and quantity of endoscopic biopsies impact cancer patient outcome

Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study

IBD impact on quality of life and perception of disease activity in Italian patients and physicians: An IBD-PODCAST study sub analysis

Adaptive Behaviors, Esophageal Anxiety, and Hypervigilance Modify the Association Between Dysphagia Perception and Histological Disease Activity in Eosinophilic Esophagitis

Rethinking Short-Chain Fatty Acids: A Closer Look at Propionate in Inflammation, Metabolism, and Mucosal Homeostasis

Pathophysiology of GERD

Hyaluronic acid and chondroitin sulfate-based medical devices: formulations, esophageal mucosal protection, and their place in the management of GERD

Efficacy of dupilumab in patients with prior exposure to topical steroids: facing second-line treatments for eosinophilic oesophagitis

THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0 THAT ASSOCIATES WITH TREATMENT OUTCOME FROM ANTI-REFLUX THERAPY

Clinical Characteristics, Endoscopic Findings, and Treatment Outcomes in Lymphocytic Esophagitis Compared to Eosinophilic Esophagitis

Gemini-Assisted Deep Learning Classification Model for Automated Diagnosis of High-Resolution Esophageal Manometry Images

Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study

Standard length of peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis

Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The “HERICIUM-UC” Two-Arm Multicentre Retrospective Study

From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis

Nursing Interventions Targeting Fatigue in Inflammatory Bowel Disease: A Systematic Review

The IBS and SIBO dilemma: Here we go again

Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review

Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis

Invited review: Bovine colostrum, a promising ingredient for humans and animals—Properties, processing technologies, and uses

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

Chicago Classification v4.0 stratifies acid burden and abnormal impedance-pH variables better than Chicago Classification v3.0

Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future

Assessment of Nutritional Status by Bioelectrical Impedance in Adult Patients with Celiac Disease: A Prospective Single-Center Study

Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions

Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn’s Disease Undergoing an Ileocolonic Resection With Ileocolonic Anastomosis

Collaborators (26)

Henit Yanai

Walter FRIES

David Drobne

Pär Myrelid

Giulio Visentin

Piotr Eder

NICOLA DE BORTOLI

Fabiana Zingone

Matteo Martinato

Alexander C. Ford

Andreas Blesl

Jason Dunn

ROSANNA IRENE COMORETTO

Carmelo SCARPIGNATO

Triana Lobaton Ortega

Gaia Griguolo

Luca Mastracci

Alessandro Armuzzi

Nicholas Sneddon

ANDREA FORMIGONI

Matteo Fassan

Melania Scarpa

Marco Scarpa

C. Prakash Gyawali

Alberto Barchi

Davide Giuseppe Ribaldone

Make your next move.